Analysis and design of randomised clinical trials involving competing risks endpoints
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis and design of randomised clinical trials involving competing risks endpoints ; volume:12 ; number:1 ; day:19 ; month:5 ; year:2011 ; pages:1-10 ; date:12.2011
Trials ; 12, Heft 1 (19.5.2011), 1-10, 12.2011
- Urheber
-
Tai, Bee-Choo
- Beteiligte Personen und Organisationen
-
Wee, Joseph
Machin, David
SpringerLink (Online service)
- DOI
-
10.1186/1745-6215-12-127
- URN
-
urn:nbn:de:1111-2016050220696
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tai, Bee-Choo
- Wee, Joseph
- Machin, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Competing risks models
Structurally Dependent Competing Risks
Competing risks model and copula
Endpoints for clinical trials in retinal diseases
Unemployment Duration: Competing and Defective Risks
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Competing risks models
Structurally Dependent Competing Risks
Competing risks model and copula
Endpoints for clinical trials in retinal diseases
Unemployment Duration: Competing and Defective Risks
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
Competing risks models
Structurally Dependent Competing Risks
Competing risks model and copula
Endpoints for clinical trials in retinal diseases
Unemployment Duration: Competing and Defective Risks
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Surrogate endpoints in trials: a call for better reporting
Endpoints in stem cell trials in ischemic heart failure
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Physical function endpoints in cancer cachexia clinical trials: systematic review 1 of the cachexia endpoints series